In perspective of clinical significance, inhibition of AT1R is an important pharmacological therapy in the management of hypertension, particularly with long-term benefits in the treatment of patients in post-myocardial infarction period and at risk for ischemic heart disease. This evidence concerns the gene AGTR1 and myocardial infarction.